FOLFOX6 as first-line treatment in metastatic gastric cancer: Preliminary results of a phase II trial.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.4091 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 4091-4091

Author(s):

A. Fontana ◽

L. Losi ◽

F. Bertolini ◽

S. Zironi ◽

R. Depenni ◽

...

Keyword(s):

Gastric Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Gastric Cancer ◽

Line Treatment ◽

Preliminary Results ◽

First Line Treatment

Download Full-text

A Randomized, Single Center Phase II Trial of Capecitabine Plus Cisplatin versus TS-1 Plus Cisplatin as First Line Treatment in Patients with advanced or Metastatic Gastric Cancer

Annals of Oncology ◽

10.1016/s0923-7534(20)33340-8 ◽

2012 ◽

Vol 23 ◽

pp. ix250

Author(s):

J. Lee ◽

S.Y. Roh ◽

E. Jeon ◽

S.H. Hong ◽

Y.H. Ko ◽

...

Keyword(s):

Gastric Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Gastric Cancer ◽

Line Treatment ◽

Single Center ◽

First Line Treatment

Download Full-text

Combination of irinotecan (CPT-11) plus oxaliplatin (L-OHP) as first-line treatment in locally advanced or metastatic gastric cancer: a multicentre phase II trial

Annals of Oncology ◽

10.1093/annonc/mdh312 ◽

2004 ◽

Vol 15 (8) ◽

pp. 1204-1209 ◽

Author(s):

J. Souglakos ◽

K. Syrigos ◽

A. Potamianou ◽

A. Polyzos ◽

I. Boukovinas ◽

...

Keyword(s):

Gastric Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Metastatic Gastric Cancer ◽

Line Treatment ◽

Multicentre Phase ◽

First Line Treatment

Download Full-text

Apatinib in Combination with S‐1 as First‐Line Treatment in Patients with Advanced Metastatic Gastric Cancer: Results from an Open, Exploratory, Single‐Arm , Phase II Trial

The Oncologist ◽

10.1002/onco.13613 ◽

2020 ◽

Author(s):

Na Zhou ◽

Chuantao Zhang ◽

Dong Liu ◽

Kewei Liu ◽

Guanqun Wang ◽

...

Keyword(s):

Gastric Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Gastric Cancer ◽

Line Treatment ◽

First Line Treatment

Download Full-text

Lapatinib with ECF/X in the first-line treatment of metastatic gastric cancer according to HER2neu and EGFR status: a randomized placebo-controlled phase II study (EORTC 40071)

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-018-3667-8 ◽

2018 ◽

Vol 82 (4) ◽

pp. 733-739 ◽

Author(s):

Markus Moehler ◽

◽

Arno Schad ◽

Annett Maderer ◽

Ajlan Atasoy ◽

...

Keyword(s):

Gastric Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Gastric Cancer ◽

Line Treatment ◽

First Line Treatment

Download Full-text

Abstract P5-17-05: Sorafenib plus Ixabepilone as First-Line Treatment for Patients with HER2-Negative Metastatic Breast Cancer: Preliminary Results of the Phase II Trial of the Sarah Cannon Research Institute

10.1158/0008-5472.sabcs12-p5-17-05 ◽

2012 ◽

Author(s):

DA Yardley ◽

J Barton ◽

N Dickson ◽

D Shipley ◽

DR Drosick ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Line Treatment ◽

Preliminary Results ◽

First Line Treatment ◽

Research Institute

Download Full-text

TOMOX compared to FOLFOX4 as first-line treatment in patients (pts) with advanced colorectal cancer (ACRC): Preliminary results of a multicenter randomized phase II trial

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.3599 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 3599-3599

Author(s):

C. Grávalos ◽

C. García-Girón ◽

A. I. León ◽

A. Salud ◽

B. Esteban ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Advanced Colorectal Cancer ◽

Phase Ii Trial ◽

Line Treatment ◽

Preliminary Results ◽

Randomized Phase Ii ◽

First Line Treatment

Download Full-text

A randomized phase II trial of docetaxel plus S-1 versus docetaxel plus cisplatin in advanced gastric cancer as a first-line treatment

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.4534 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 4534-4534 ◽

Author(s):

H. Jeung ◽

C. Im ◽

S. Rha ◽

J. Ahn ◽

S. Shin ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Line Treatment ◽

Randomized Phase Ii ◽

First Line Treatment

Download Full-text

Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer

British Journal of Cancer ◽

10.1038/sj.bjc.6602697 ◽

2005 ◽

Vol 93 (2) ◽

pp. 190-194 ◽

Author(s):

F Lordick ◽

S Lorenzen ◽

J Stollfuss ◽

U Vehling-Kaiser ◽

F Kullmann ◽

...

Keyword(s):

Gastric Cancer ◽

Folinic Acid ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Gastric Cancer ◽

Line Treatment ◽

First Line Treatment

Download Full-text

Phase II study and biomarker analysis of cetuximab in combination with oxaliplatin, 5-fluorouracil, leucovorin as first-line treatment in patients with recurrent or metastatic gastric cancer

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.4549 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 4549-4549 ◽

Author(s):

S. Han ◽

S. R. Park ◽

K. Lee ◽

H. Song ◽

M. A. Kim ◽

...

Keyword(s):

Gastric Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Gastric Cancer ◽

Line Treatment ◽

Biomarker Analysis ◽

First Line Treatment

Download Full-text

3518 POSTER Cetuximab with Irinotecan/FA/5-FU as first-line treatment in advanced gastric cancer: Preliminary results of a non-randomized multicenter AIO phase II study

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(07)71021-2 ◽

2007 ◽

Vol 5 (4) ◽

pp. 264 ◽

Author(s):

M. Moehler ◽

T. Trarbach ◽

T. Seufferlein ◽

S. Kubicka ◽

S. Kanzler ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

Preliminary Results ◽

First Line Treatment

Download Full-text